ForwardVue Pharma
BioTech/Drugs - Cambridge, N/A, us
ForwardVue Pharma Employees
ForwardVue Pharma Senior Management
ForwardVue Pharma Details
ForwardVue Pharma is an emerging biopharmaceutical company developing a small synthetic compound caroboxyamidotriazole, that acts via the novel mechanism of ORAI-1 inhibition and can be formulated to deliver potent anti-angiogenic effects for 6-12 months. Carboxyamidotriazole has been administered to over 900 patients systemically to treat advanced cancer thereby allowing more rapid progress to Phase 2 once IND enabling ocular toxicity is completed. ForwardVue Pharma has secured initial seed round funding in order to advance pre-clinical development of potent long acting anti-angiogenic molecules directed against diabetic eye disease and neovascular age related macular degeneration.
ForwardVue Pharma Technologies
Email Providers
Outlook
Hosting
GoDaddy Hosting
Other
Mobile Friendly